Revenue Recognition (Tables)

6 Months Ended

Jun. 30, 2020

Accounting Policies [Abstract]

Disaggregation of Revenue

Revenues for the three and six months ended June 30, 2020 and 2019 were as follows:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2020		2019		2020		2019
	(Amounts in thousands)
Product revenue	$	87,432	$	70,670	$	163,492	$	131,282
Royalty and other income		30		22		60		44
Total revenue	$	87,462	$	70,692	$	163,552	$	131,326

Revenue from Significant Customers

Revenue from significant customers that represent 10% or more of the Company’s total revenue is as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2020		2019		2020		2019
	(Amounts in thousands)
Cytiva (formerly GE Healthcare)	$	10,479	$	11,083	$	16,606	$	18,749
MilliporeSigma	$	10,674	$	9,487	$	21,566	$	18,894

Summary of Receivables and Deferred Revenue from Contracts with Customers

The following table provides information about receivables and deferred revenues from contracts with customers as of June 30, 2020 (amounts in thousands):

	2020
Balances from contracts with customers only:
Accounts receivable	$	48,779
Deferred revenue (included in accrued liabilities in the consolidated balance sheets)		7,276
Revenue recognized during the six month period ended June 30, 2020 relating to:
The beginning deferred revenue balance	$	2,747
Changes in pricing related to products or services satisfied in previous periods		—